Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma-Reference-Cited by-同舟云学术

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma

Published:2019-06-17 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Berlow Noah E.^ORCID,Rikhi Rishi,Geltzeiler Mathew,Abraham Jinu,Svalina Matthew N.,Davis Lara E.,Wise Erin,Mancini Maria,Noujaim Jonathan,Mansoor Atiya,Quist Michael J.,Matlock Kevin L.,Goros Martin W.,Hernandez Brian S.,Doung Yee C.,Thway Khin,Tsukahara Tomohide,Nishio Jun,Huang Elaine T.,Airhart Susan,Bult Carol J.,Gandour-Edwards Regina,Maki Robert G.,Jones Robin L.,Michalek Joel E.,Milovancev Milan,Ghosh Souparno,Pal Ranadip,Keller Charles

Funder

Scott Carter Foundation

SuperSam Foundation

Damon Runyon Cancer Research Foundation

St. Baldrick's Foundation

Prayers for Elijah

AAO-HNSF Saidee Keller Grant

AAO-HNSF Grant

National Science Foundation

Centralized Otolaryntology Research Effort

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5681-6.pdf

Reference53 articles.

1. American Cancer Society. Cancer Facts & Figures 2019. Atlanta: American Cancer Society; 2019. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf .

2. Parsons D, Roy A, Yang Y, et al. Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors. JAMA Oncol. 2016;2:616–24. https://doi.org/10.1001/jamaoncol.2015.5699 .

3. Mody RJ, Prensner JR, Everett J, Parsons DW, Chinnaiyan AM. Precision medicine in pediatric oncology: Lessons learned and next steps. Pediatr Blood Cancer. 2017;64. https://doi.org/10.1002/pbc.26288 .

4. Somaiah N, von Mehren M. New drugs and combinations for the treatment of soft-tissue sarcoma: a review. Cancer Manag Res. 2012;4:397–411. https://doi.org/10.2147/CMAR.S23257 .

5. Sos ML, et al. Predicting drug susceptibility of non–small cell lung cancers based on genetic lesions. J Clin Invest. 2009;119:1727–40. https://doi.org/10.1172/JCI37127 .

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers;Nature Medicine;2024-04

2. Potential of CDC25 phosphatases in cancer research and treatment: key to precision medicine;Frontiers in Pharmacology;2024-01-19

3. Translational Aspects of Epithelioid Sarcoma: Current Consensus;Clinical Cancer Research;2023-11-28

4. Directional preference for glioblastoma cancer cell membrane encapsulated nanoparticle population: A probabilistic approach for cancer therapeutics;Frontiers in Immunology;2023-03-29

5. Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biology;Clinical and Translational Medicine;2022-07